IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers
This study is ongoing, but not recruiting participants.
Sponsor:
GeneOne Life Science, Inc.
Collaborators:
Inovio Pharmaceuticals
Walter Reed Army Institute of Research (WRAIR)
Information provided by (Responsible Party):
GeneOne Life Science, Inc.
ClinicalTrials.gov Identifier:
NCT02670187
First received: January 27, 2016
Last updated: July 26, 2016
Last verified: January 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2017 |
| Estimated Primary Completion Date: | May 2017 (Final data collection date for primary outcome measure) |